Payment overview · 2025
General Payments
$56.64
2 reported records · 2 companies
Healthcare provider profile · identity verified
Atef Labib Yacoub, M.D.
Allopathic & Osteopathic Physicians|Urology · MONTEBELLO, CA · NPI 1740339894
Verified facts
What the public records show
CMS Open Payments records show Atef Labib Yacoub, M.D. received $56.64 in general payments during 2025 across 2 reported records.
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 59.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $33.61 | 59.3% | 1 | 2025 |
| PROGENICS PHARMACEUTICALS, INC. | Unresolved — no canonical attribution shown | $23.03 | 40.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $56.64 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33.61 | 1 | 2025 |
Source payment records
|
|||||
| PYLARIFY Normalized: pylarify |
Drug | PROGENICS PHARMACEUTICALS, INC. | $23.03 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 895 | 155 |
| Amlodipine Besylate | Amlodipine Besylate | 468 | 81 |
| Metformin Hcl | Metformin Hcl | 371 | 62 |
| Tamsulosin Hcl | Tamsulosin Hcl | 356 | 106 |
| Lactulose | Lactulose | 338 | 43 |
| Losartan Potassium | Losartan Potassium | 308 | 50 |
| Gabapentin | Gabapentin | 303 | 53 |
| Eliquis | Apixaban | 291 | 29 |
| Levothyroxine Sodium | Levothyroxine Sodium | 286 | 50 |
| Famotidine | Famotidine | 280 | 52 |
| Pantoprazole Sodium | Pantoprazole Sodium | 271 | 44 |
| Furosemide | Furosemide | 258 | 48 |
| Divalproex Sodium | Divalproex Sodium | 206 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 198 | 29 |
| Lisinopril | Lisinopril | 195 | 30 |
| Metoprolol Tartrate | Metoprolol Tartrate | 190 | 30 |
| Memantine Hcl | Memantine Hcl | 180 | 31 |
| Metoprolol Succinate | Metoprolol Succinate | 177 | 24 |
| Benztropine Mesylate | Benztropine Mesylate | 168 | 23 |
| Omeprazole | Omeprazole | 158 | 26 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 152 | 56 |
| Finasteride | Finasteride | 151 | 34 |
| Baclofen | Baclofen | 143 | 24 |
| Levetiracetam | Levetiracetam | 134 | 22 |
| Donepezil Hcl | Donepezil Hcl | 127 | 29 |
| Risperidone | Risperidone | 127 | 27 |
| Potassium Chloride | Potassium Chloride | 122 | 23 |
| Benazepril Hcl | Benazepril Hcl | 118 | 15 |
| Carvedilol | Carvedilol | 118 | 20 |
| Jardiance | Empagliflozin | 113 | 14 |
| Ibuprofen | Ibuprofen | 109 | 45 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 107 | 23 |
| Quetiapine Fumarate | Quetiapine Fumarate | 106 | 19 |
| Levocarnitine | Levocarnitine | 103 | 18 |
| Olanzapine | Olanzapine | 102 | 18 |
| Chlorthalidone | Chlorthalidone | 94 | 13 |
| Naproxen-Esomeprazole Mag | Naproxen/Esomeprazole Mag | 82 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 80 | 20 |
| Diclofenac Sodium | Diclofenac Sodium | 79 | 12 |
| Mirtazapine | Mirtazapine | 75 | 17 |
| Fenofibrate | Fenofibrate Nanocrystallized | 74 | 16 |
| Naproxen | Naproxen | 74 | 14 |
| Montelukast Sodium | Montelukast Sodium | 71 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 66 | 15 |
| Rexulti | Brexpiprazole | 65 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 63 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 62 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 62 | 22 |
| Clopidogrel | Clopidogrel Bisulfate | 62 | 12 |
| Glipizide | Glipizide | 62 | 11 |
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 61 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 60 | suppressed |
| Januvia | Sitagliptin Phosphate | 59 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 59 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 58 | 17 |
| Bicalutamide | Bicalutamide | 56 | 17 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 54 | 53 |
| Midodrine Hcl | Midodrine Hcl | 53 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 52 | suppressed |
| Entresto | Sacubitril/Valsartan | 51 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 51 | 13 |
| Ventolin Hfa | Albuterol Sulfate | 51 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 50 | 11 |
| Xarelto | Rivaroxaban | 50 | suppressed |
| Latanoprost | Latanoprost | 49 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 48 | suppressed |
| Humulin R | Insulin Regular, Human | 48 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 48 | suppressed |
| Sucralfate | Sucralfate | 48 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 46 | suppressed |
| Nystatin | Nystatin | 45 | 14 |
| Aripiprazole | Aripiprazole | 44 | suppressed |
| Spironolactone | Spironolactone | 43 | suppressed |
| Trulicity | Dulaglutide | 43 | suppressed |
| Ertapenem | Ertapenem Sodium | 42 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 39 | 16 |
| Metformin Er Gastric | Metformin Hcl | 39 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 38 | 16 |
| Amiodarone Hcl | Amiodarone Hcl | 37 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 37 | suppressed |
| Lacosamide | Lacosamide | 37 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 36 | 21 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 36 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 33 | suppressed |
| Haloperidol | Haloperidol | 33 | suppressed |
| Allopurinol | Allopurinol | 32 | suppressed |
| Atenolol | Atenolol | 32 | suppressed |
| Nifedipine Er | Nifedipine | 32 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 31 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 31 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 28 | 24 |
| Clotrimazole | Clotrimazole | 28 | 13 |
| Xifaxan | Rifaximin | 28 | suppressed |
| Gemtesa | Vibegron | 27 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Fenofibrate | Fenofibrate | 26 | suppressed |
| Ketoconazole | Ketoconazole | 26 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 26 | 16 |
| Vascepa | Icosapent Ethyl | 26 | suppressed |
| Clonazepam | Clonazepam | 25 | suppressed |
| Levofloxacin | Levofloxacin | 25 | 24 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 25 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 25 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 24 | suppressed |
| Lidocaine | Lidocaine | 24 | 11 |
| Metformin Hcl Er | Metformin Hcl | 24 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 24 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 22 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 22 | suppressed |
| Lamotrigine | Lamotrigine | 22 | suppressed |
| Procrit | Epoetin Alfa | 22 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 21 | suppressed |
| Timolol Maleate | Timolol Maleate | 21 | suppressed |
| Paliperidone Er | Paliperidone | 20 | suppressed |
| Primidone | Primidone | 20 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 20 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 20 | suppressed |
| Entacapone | Entacapone | 19 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 18 | suppressed |
| Rhopressa | Netarsudil Mesylate | 18 | suppressed |
| Ezetimibe | Ezetimibe | 17 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Lumigan | Bimatoprost | 17 | suppressed |
| Meloxicam | Meloxicam | 17 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 17 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 17 | suppressed |
| Acetazolamide | Acetazolamide | 16 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 16 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 16 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 16 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 16 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Imipenem-Cilastatin Sodium | Imipenem/Cilastatin Sodium | 15 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 15 | suppressed |
| Simvastatin | Simvastatin | 15 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Prednisone | Prednisone | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 13 | suppressed |
| Cephalexin | Cephalexin | 13 | 11 |
| Desmopressin Acetate | Desmopressin Acetate | 13 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 13 | suppressed |
| Mresvia | Rsv Vaccine, Pref, Mrna/Pf | 13 | 12 |
| Phenobarbital | Phenobarbital | 13 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 13 | suppressed |
| Amantadine | Amantadine Hcl | 12 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 12 | suppressed |
| Cyclosporine | Cyclosporine | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Norethindrone | Norethindrone | 12 | suppressed |
| Permethrin | Permethrin | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Repaglinide | Repaglinide | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Acamprosate Calcium | Acamprosate Calcium | 11 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Calcium Acetate | Calcium Acetate | 11 | suppressed |
| Clonidine | Clonidine | 11 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Isoniazid | Isoniazid | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 11 | suppressed |
| Ozempic | Semaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $56.64 · 2 records | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA, PYLARIFY | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error